Search Results On insulin commercialization

insulin commercialization

Articles Galleries Videos
  • Kiran Mazumdar-Shaw, Research Services & Branded Formulations, biocon recommends a dividend of rs 5 per share, Insulin commercialization

    Biocon recommends a dividend of Rs. 5 per share  2012-04-28 09:38:06

    Biocon posts Revenues at Rs 2,148 Crores;   EBITDA at Rs 579 Crores;   PAT at Rs 338 Crores Commenting on the results, Chairman and Managing Director of Biocon Kiran Mazumdar-Shaw stated, “I am pleased with the overall performance that we have...

    Keywords: net licensing income, Biocon, Research Services & Branded Formulations, Biocon Research Center

    Read More